賦µÀÓªÑø,Enteral nutritionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« IgGÑÇÀà,IgG subclassesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ô˶¯·¢Óý,motor developmentÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·Î±íÃæ»îÐÔÎïÖÊÏà¹Øµ°°×ÖÊÀà,Pulmonary surfactant-associated proteinsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼«µÍ³öÉúÌåÖÊÁ¿,very low birth weightÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄÉÃ׺ìÉ«ÔªËØÎø,Nano red elemental seleniumÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ºôÎüÖÎÁÆ,respiratory therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÖÇÁ¦²âÊÔ,intelligence testÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« p16ink4a»ùÒò,p16ink4a geneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÉöÑ­»·,renal circulationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« δ½áºÏµ¨ºìËØ,Unconjugated bilirubinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸ßƵÕðµ´Í¨Æø,High frequency oscillatory ventilationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÓÅÏȲßÂÔ,priority strategyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Éñ¾­²¡Ñ§¼ì²é,Neurologic examinationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ȱÑõȱѪÄÔËðÉË,hypoxic-ischemic brain damageÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÁªºÏÕï¶Ï,combined diagnosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ±ÈÀý¸¨ÖúÍ¨Æø,Proportional assist ventilationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÂýÐԷβ¿¼²²¡,chronic lung diseaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ³ÖÐø·Î¶¯Âö¸ßѹ,persistent pulmonary hypertensionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·Ç½áºÏµ¨ºìËØ,unconjugated bilirubinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ιËÇ·½·¨,Feeding methodsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¹ÇÐγɵ°°×4,bone morphogenetic protein 4Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« Á£Ï¸°û¼¯Âä´Ì¼¤Òò×Ó(G-CSF),granulocyte colony-stimulating factor(G-CSF)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ³¦µÀÎ¹Ñø,enteral feedingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« XÏßÌå²ãÉãÓ°Êõ,X-ray computed tomographyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« »Ø¹Ëµ÷²é,Retrospective surveyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄÔȱÑõȱѪ,Hypoxic ischemic brain damageÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ôç²úÊó,premature ratÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¹Èë׸ÊëÄS×ªÒÆÃ¸,glutathione S-transferasesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÖØ×é´Ùºìϸ°ûÉú³ÉËØ,recombinant human erythropoietinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Àɸñº±×é֯ϸ°ûÔöÉúÖ¢,langerhans cell histiocytosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄÔÊÒÖÜΧ°×ÖÊÈí»¯²¡,periventricular leukomalaciaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾²Âö±ûÖÖÇòµ°°×,Intravenous immunoglobulinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼×»ù±û¶þËá,Methylmalonic acidÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ȱÑõÐÔÐļ¡ËðÉË,ischemic myocardial damageÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ò©Ãô¼ì²â,Drug sensitivity testÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾²ÂöÃâÒßÇòµ°°×,intravenous immunoglobulinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¹¦ÄÜËðº¦,functional impairmentÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ³¦¸ÎÑ­»·,enterohepatic circulationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« É«ËØÊ§½ûÖ¢,Incontinentia pigmentiÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸ßδ½áºÏµ¨ºìËØÑªÖ¢,unconjugated hyperbilirubinemiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ³¦Ö×Áö/Õï¶Ï,INTESTINAL NEOPLASMS/diagÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ´¹Ö±¸ÐȾ,vertical transmissionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÐÂÉúÍÃ,Newborn rabbitÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ѧϰ¡¢¼ÇÒä,learning and memoryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸Ð¾õÔ˶¯¹¦ÄÜ,sensorimotor functionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÀÒËáËó¾úCGMCC0313.1,Clostridium butyricum CGMCC0313.1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ƽ¹ûÏØ,Pingguo countyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« RHϵͳ,RH systemÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÖÐDZ·üÆÚ·´Ó¦,middle latency responsesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·Î±íÃæ»îÐÔµ°°×D,pulmonary surfactant protein DÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ôç²ú´óÊó,Premature ratsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« P2X_7ÊÜÌå,P2X_7 ReceptorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ѪƬ,blood sliceÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄÔÊÒÖÜΧ-ÄÔÊÒÄÚ³öѪ,Periventricular-intraventricular hemorrhageÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ѪÂú²Ý,Sambucus Adnata WallÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µ¥ÍÙÒºËáËļºÌÇÉñ¾­½ÚÜÕ֬į,monosialotetrahexosyl ganglioside sodiumÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÐÂÉú¶ùȱÑõȱѪÐÔÄÔ²¡(HIE),hypoxic-ischemic encephalopathy(HIE)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÏÈÌìÐÔ¼××´ÏÙ¹¦ÄܵÍÏÂÖ¢,Congenital hypothyroidismÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÖÓ»ùÒò,Clock geneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ±ÇËÇÎ¹Ñø,nasal feedingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ±ÇÈû³ÖÐøÆøµÀÕýÑ¹Í¨Æø,nasal continuous positive airway pressureÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÐÂÉú¶ù·Î͸Ã÷Ĥ²¡,Hyaline membrane diseaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄÔȱѪȱÑõ,cerebral ischemia and hypoxiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÔçÆÚ´¥Ãþ,neonatal handlingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÇÐÖµ,cut-off valueÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ͸Ã÷Ĥ²¡,Hyaline membrane diseaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒÅ´«´úл²¡,inherited metabolic diseasesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÊÓÍøÄ¤ËðÉË,retinal damageÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ͷ­B³¬,cranial sonographyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« S100BBµ°°×,S100BB proteinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÆøµÀÕýÑ¹Í¨Æø,Positive airway pressureÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ´«Í³»úÐµÍ¨Æø,conventional mechanical ventilationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÓлúËáѪ֢,organic acidemiasÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÁÙ´²·Ö¶È,Clinical gradingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ±ÇÈû³ÖÐøÕýÑ¹Í¨Æø,Nasal continuous positive airway pressureÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ì¥·àÎüÈë×ÛºÏÖ¢,Meconium aspiration syndromeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« »»ÑªÊõ,Exchange transfusionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ðåÕ¶¾3ÐÍ,Herpesvirus 3Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾Ö²¿Ñõ±¥ºÍ¶È,Regional oxygen saturationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« G6PDȱÏÝ,G6PD deficiencyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÊԹܷ¨,Tube methodÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÐÂÉú¶ù¸ÎÑ×,Neonatal HepatitisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ѪÄÔ¼¹ÒºÆÁÕÏ,blood brain barrierÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« NBNAÆÀ·Ö,NBNA scoreÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ê©½ÝÒò,Monosialo gangliosides-1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« Éú³¤×·¸Ï,catch-up growthÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ABOÈÜѪ²¡,ABO hemolytic diseaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Á×ËἡËἤøͬ¹¦Ã¸,creatine phosphokinase MB isozmyeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÊÒ¹ÜĤϳöѪ,subependymal hemorrhagesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼ÆËã»úXÏ߶ϲãɨÃè,X-ray computer tomographyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Æø¹Ü×¢Èë,Intratracheal instillationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ó«¹â°ßµã·¨,Fluorescence spot testÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Î¹ÑøÀ§ÄÑ,feeding intoleranceÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ôç²ú¶ùºôÎüÔÝÍ£,Apnea of prematurityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÌåÖØÏ½µ,weight lossÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ×ãÔÂÐÂÉú¶ù,Term infantsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÆêѪµ¨ºìËØ,cord blood bilirubinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾­Æ¤µ¨ºìËØ,transcutaneous bilirubinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¹âÕÕÁÆ·¨,light therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
 ÉÏÒ»Ò³ 2 3 4 5 6 7 8 9 ÉÏÒ»Ò³